Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,017–2,024 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Immunic Inc. IMU-838 Crohn’s disease Phase 2 Trial Completed Oral Gastroenterology
Immunic Inc. Vidofludimus calcium (IMU-838) - (RAPID_REVIVE) Post COVID Syndrome Phase 2 Enrollment Initiation Oral N/A
Immunic Inc. Vidofludimus Calcium - (ENSURE) Progressive Multiple Sclerosis Phase 3 Ongoing Oral Neurology
Immunic Inc. Vidofludimus Calcium (IMU-838) - (CALLIPER) Progressive Multiple Sclerosis Phase 2 Data Released Oral Neurology
Immunic Inc. IMU-838 - (CALVID-1) COVID-19 Phase 2 Data Released oral COVID-19
Immunic Inc. IMU-838 - (CALDOSE-1) Ulcerative colitis Phase 2 Trial Completed Oral Gastroenterology
Immunic Inc. IMU-838 Primary Sclerosing Cholangitis Phase 2 Trial Completed Oral Gastroenterology
Immunic Inc. IMU-838 and Oseltamivir (Tamiflu) - (IONIC) COVID-19 Phase 2b Trial Completed Oral COVID-19